Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy

Journal of Clinical Oncology

Volumn 18, Issue 9, 2000, Pages 1914-1920

  Sabbatini, Roberto ^a   Federico, Massimo ^a   Morselli, Monica ^a   Depenni, Roberta ^a   Cagossi, Katia ^a   Luppi, Mario ^a   Torelli, Giuseppe ^a   Silingardi, Vittorio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; CA 15-3 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; KI 67 ANTIGEN; MASPIN; METHOTREXATE; TAMOXIFEN;

ADULT; ARTICLE; BLOOD CYTOLOGY; BREAST CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CELL ISOLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034059619     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.9.1914     Document Type: Article

References (26)

1. Ross AA, Cooper BW, Lazarus HM, et al: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605-2610, 1993
2. Pantel K, Izbicki JR, Angstwurm M, et al: Immunocytochemical detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 53:1027-1031, 1993
3. Pelkey TJ, Frierson HF Jr, Bruns DE: Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 42:1369-1381, 1996
4. Schulze R, Schulze M, Wischnik A, et al: Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients. Bone Marrow Transplant 19:1223-1228, 1997
5. Cote RJ, Beattie EJ, Chaiwun B, et al: Detection of occult bone marrow micrometastasis in patients with operable lung carcinoma. Ann Surg 4:415-425, 1995
6. Naito H, Kuzumaki N, Uchino J, et al: Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction. Eur J Cancer 27:762-765, 1991
7. Jung K, Henke W, Lein M, et al: Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 78:2445-2447, 1996
8. Neumaier M, Gerhard M, Wagener C: Diagnosis of micrometastases by amplification of tissue-specific genes. Gene 159:43-47, 1995
9. Seiden MV, Kantoff PW, Krithivas K, et al: Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 12:2634-2639, 1994
10. Mattano LA, Moss TJ, Enerson SG: Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 52:4701-4705, 1992
11. Datta YH, Adams PT, Drobyski WR, et al: Sensitive detection of occult breast cancer by reverse-transcriptase polymerase chain reaction. S Clin Oncol 12:475-482, 1994
12. Fields KK, Elfenbein GJ, Tradeau WL, et al: Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14:1868-1876, 1996
13. Wood DP Jr, Banks ER, Humphreys S, et al: Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in bone marrow. J Histochem Cytochem 42:505-511, 1994
14. Zippelius A, Kufer P, Honold G, et al: Limitations of reverse-transcriptase polymerase chain reaction analysis for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 15:2701-2708, 1997
15. Krismann M, Todt B, Schroder J, et al: Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 13:2769-2775, 1495
16. Bostick PJ, Chattetjee S, Chi DD, et al: Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16:2632-2640, 1998
17. Zou Z, Anisowicz A, Hendrix MJC, et al: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526-529, 1994
18. Luppi M, Morselli M, Bandieri E, et al: Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene. Ann Oncol 7:619-624, 1996
19. Chomezynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
20. Roth MS, Antin JH, Bingham EL, et al: Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood 74:882-885, 1989
21. Izbicki JR, Hosch SB, Pichlmeier U, et al: Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 337:1188-1194, 1997
22. Vredenburgh JJ, Silva O, Broadwater G, et al: The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support. Biol Blood Marrow Transplant 3:91-97, 1997
23. Diel IJ, Kaufmann M, Goerner R, et al: Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis. J Clin Oncol 10:1534-1539, 1992
24. Thor A, Viglione MJ, Ohuchi N, et al: Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrow. Breast Cancer Res Treat 11:133-145, 1998
25. Brugger W, Bross KJB, Glatt M, et al: Mobilisation of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumor. Blood 83:636-640, 1994
26. Cooper BW, Moss TJ, Ross AA, et al: Occult tumor contamination of hemopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer. J Clin Oncol 16:3509-3517, 1998